- Title
- Time Course Of Adverse Events In Primary Advanced Or Recurrent Endometrial Cancer Treated With Dostarlimab Plus Chemotherapy In The ENGOT-EN-6-NSGO/GOG-3031/RUBY Trial
- Creators
- Elizabeth LokichTrine Lembrecht JørgensenDestin BlackDavid CibulaLucy GilbertAntonella SavareseMatthew A. PowellRebecca HerbertsonSarah E. GillBradley J. MonkNicole NevadunskyKari L. RingNoelle ClovenIwona PodzielinskiTashanna MyersChristine DabrowskiShadi StevensLyndsay WillmottMansoor Raza Mirza
- Publication Details
- International journal of gynecological cancer, Vol.35(2), p.101722
- Identifiers
- 991006147431102656
- Academic Unit
- Obstetrics & Gynecology
- Language
- English
- Resource Type
- Journal article
Journal article
Time Course Of Adverse Events In Primary Advanced Or Recurrent Endometrial Cancer Treated With Dostarlimab Plus Chemotherapy In The ENGOT-EN-6-NSGO/GOG-3031/RUBY Trial
International journal of gynecological cancer, Vol.35(2), p.101722
02/2025
Metrics
2 Record Views